Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
Ana Maria Raymundi, Thiago Rodrigues da Silva, Jeferson Machado Batista Sohn, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Ginsenoside Rg1 in neurological diseases: From bench to bedside
Shaojie Yang, Jing-ji Wang, Ping Cheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 913-930
Open Access | Times Cited: 55
Biopsychosocial Model Social Anxiety and Substance Use Revised
Julia D. Buckner, Paige E. Morris, Cristina N. Abarno, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 6
Closed Access | Times Cited: 35
The Roles of Cannabis Potency and Gender in Cannabis Dependence and Anxiety in Recent Cannabis Users with Trauma Exposure Histories
Thomas Snooks, Sherry H. Stewart, Pablo Romero‐Sanchiz, et al.
Pharmacological Research (2025), pp. 107586-107586
Open Access
Impaired learning, memory, and extinction in posttraumatic stress disorder: translational meta-analysis of clinical and preclinical studies
Milou S. C. Sep, Elbert Geuze, Marian Joëls
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
Michelle Sexton, José M. Garcia, Aminah Jatoi, et al.
JNCI Monographs (2021) Vol. 2021, Iss. 58, pp. 86-98
Open Access | Times Cited: 25
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
Beatriz Zanutto Salviato, Ana Maria Raymundi, Thiago Rodrigues da Silva, et al.
Neuropharmacology (2021) Vol. 196, pp. 108684-108684
Closed Access | Times Cited: 23
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112925-112925
Open Access | Times Cited: 18
Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping
Mustafa Al’Absi, Alicia M. Allen
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 21
Impact of Dietary Fat and Oral Delivery System on Cannabigerol Pharmacokinetics in Adults
Galaxie Story, Junghak Lee, Gil’ad N. Cohen, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 2
Assessment of the effect of cannabis use before partnered sex on women with and without orgasm difficulty
S Mulvehill, Jordan Tishler
Sexual Medicine (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Effects of cannabidiol, with and without ∆9-tetrahydrocannabinol, on anxiety-like behavior following alcohol withdrawal in mice
Mariam Melkumyan, Vibha M. Annaswamy, Alexandra Evans, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
A review of the effects of acute and chronic cannabinoid exposure on the stress response
Nicholas C. Glodosky, Carrie Cuttler, Ryan J. McLaughlin
Frontiers in Neuroendocrinology (2021) Vol. 63, pp. 100945-100945
Open Access | Times Cited: 17
“Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients
Guillermo Moreno‐Sanz, Alvaro Madiedo, Michael T. Lynskey, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2576-2576
Open Access | Times Cited: 12
Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
Luca Steardo, Elvira Anna Carbone, Giulia Menculini, et al.
Life (2021) Vol. 11, Iss. 3, pp. 214-214
Open Access | Times Cited: 14
Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces
Lucas Gazarini, Cristina Aparecida Jark Stern, Reinaldo Ν. Takahashi, et al.
Neuroscience (2021) Vol. 497, pp. 118-133
Closed Access | Times Cited: 13
Nutraceutical Interventions for Post-Traumatic Stress Disorder in Animal Models: A Focus on the Hypothalamic–Pituitary–Adrenal Axis
Mudan Cai, Hee Ra Park, Eun Jin Yang
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 898-898
Open Access | Times Cited: 9
Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli
Cora E. Smiley, Heyam K. Saleh, Katherine E. Nimchuk, et al.
Behavioural Brain Research (2021) Vol. 415, pp. 113517-113517
Open Access | Times Cited: 12
Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction
Jaqueline Maisa Franzen, Felipe Vanz, Isabel Werle, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 7-18
Closed Access | Times Cited: 8
Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users
Gerhard Nahler
Onco (2024) Vol. 4, Iss. 4, pp. 287-321
Open Access | Times Cited: 1
Phytocannabinoids as Chemotherapy Adjuncts – a User Guide
Gerhard Nahler
(2024)
Open Access | Times Cited: 1
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 1
Pharmacological, Somatic, and Behavioral Augmentations of PE
Claire M. Bird, Megan E. Douglas, Mark B. Powers
(2024), pp. 209-229
Closed Access | Times Cited: 1
The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110301-110301
Closed Access | Times Cited: 9
Effects of delta-9 tetrahydrocannabinol on fear memory labilization and reconsolidation: A putative role of GluN2B-NMDA receptor within the dorsal hippocampus
Ana Maria Raymundi, Jeferson Machado Batista Sohn, Bruna Wuilleumier Salemme, et al.
Neuropharmacology (2022) Vol. 225, pp. 109386-109386
Closed Access | Times Cited: 5
Left hemisphere lateralization of the limbic system and frontoparietal network (FPN) correlates with positive and negative symptom improvement following cannabidiol (CBD) administration in psychosis and ultra-high risk (UHR) populations: A voxel-wise meta-analysis
Zachary P. Pierce, Andrew S. Bogatz, Emily Johnson, et al.
Journal of Psychiatric Research (2024) Vol. 175, pp. 160-169
Closed Access
Page 1 - Next Page

Scroll to top